US Senator Rubio Calls Top Venezuelan Official Diosdado Cabello the New Pablo Escobar

19
(Wikimedia)
Rubio has been one of the leading US politicians fighting for the cause in Venezuela. (Wikimedia)

EspañolMembers of the United States Congress met to discuss the crumbling situation in Venezuela this week, during which Republican Florida Senator Marco Rubio called Diosdado Cabello — President Nicolás Maduro’s number-two man — the country’s version of Pablo Escobar.

Escobar was the renowned Colombian drug lord whose cartel was responsible for the vast majority of the cocaine that entered the United States during the 1980s. Cabello, along with Vice President Tareck El Aissami, have been accused of running major drug trafficking rings out of Venezuela.

Subscribe to our daily newsletter

“There are also very strong allegations made by some people about the role of Diosdado Cabello, an individual who, in my perspective, based on everything I have seen, is not simply a drug-trafficking leader,” Rubio said. “In my opinion, he is the Pablo Escobar of Venezuela.”

Rubio also spoke about China’s move to finance Venezuela —  a decision he claimed would back-fire. Maduro’s country is a failed state, he argued, whose only hope is to function on a semi-normal economic level, let alone pay back debts to international partners.

Once the meeting ended, Rubio had more to say about Cabello. “I would not say it if I didn’t have full confidence. It’s up to the Justice Department to take action at the right time. … He is a very dangerous man. More than a political figure, he’s a figure of drug trafficking. ”

Rubio has been one of the leading US politicians fighting for the cause in Venezuela. For months, he has denounced the crimes committed by Maduro’s regime.

Cabello — who was President of the National Assembly, Venezuela’s parliament — has been made one of the most powerful men in the Maduro regime and thus a prominent leader of drug trafficking in the region.

Subscribe to our daily newsletter
Sign up here to get the latest news, updates and special reports delivered directly to your inbox.
You can unsubscribe at any time